agilon health inc. logged a -1.6% change during today's evening session, and is now trading at a price of $12.87 per share.
agilon health inc. returned losses of -20.5% last year, with its stock price reaching a high of $29.44 and a low of $10.41. Over the same period, the stock underperformed the S&P 500 index by -44.1%. As of April 2023, the company's 50-day average price was $14.53. agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. Based in Austin, TX, the large-cap Health Care company has 747 full time employees. agilon health inc. has not offered a dividend during the last year.
Growing Revenues With Increasing Reinvestment in the Business:
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Revenue (MM) | $794 | $1,218 | $1,834 | $2,708 | $4,191 |
| Revenue Growth | n/a | 53.36% | 50.5% | 47.7% | 54.74% |
| Operating Margins | -13% | -5% | -21% | -4% | -2% |
| Net Margins | 0% | -5% | 0% | 0% | 0% |
| Net Income (MM) | -$0 | -$60 | -$0 | -$0 | -$0 |
| Net Interest Expense (MM) | $9 | $8 | $6 | $25 | $41 |
| Depreciation & Amort. (MM) | $41 | $14 | $15 | $14 | $19 |
| Free Cash Flow (MM) | -$107 | -$55 | -$155 | -$146 | -$160 |
| Capital Expenditures (MM) | $3 | $2 | $7 | $15 | $15 |
agilon health inc. does not have a meaningful trailing P/E ratio since its earnings per share are currently in the red. Based on its EPS guidance of $0.02, the company has a forward P/E ratio of 726.5. In comparison, the average P/E ratio for the Health Care sector is 30.21. Furthermore, agilon health inc. is likely overvalued compared to the book value of its equity, since its P/B ratio of 5.99 is higher than the sector average of 4.08.
agilon health inc. Has an Analyst Consensus of Strong Upside Potential:
The 15 analysts following agilon health inc. have set target prices ranging from $12.0 to $25.0 per share, for an average of $19.27 with a buy rating. As of April 2023, the company is trading -24.6% away from its average target price, indicating that there is an analyst consensus of strong upside potential.
agilon health inc. has an unusually large proportion of its shares sold short because 42.6% of the company's shares are sold short. Institutions own 111.9% of the company's shares, and the insider ownership rate stands at 1.13%, suggesting a small amount of insider investors. The largest shareholder is Clayton, Dubilier & Rice, LLC, whose 25% stake in the company is worth $1,286,999,988.
